While at Kirkland, Charles' representative matters have included:
- GLP in the $18.7 billion sale of its U.S. logistics business to Blackstone, the largest-ever private real estate transaction globally.
- GlaxoSmithKline in its $12.7 billion joint venture with Pfizer to combine their consumer health businesses.
- Nordic Capital in its acquisition of Orchid Orthopedic Solutions from Altor Equity Partners.
- Abry Partners in its acquisition of Aftermath from Serent Capital.
- Trilantic Capital Partners on the sale of a portfolio company to Ontario Teacher’s Pension Plan Board.
- Trilantic Capital Partners on the acquisition of Sunbelt Transformer from Grey Mountain Partners.
- Starr Investment Holdings, LLC in its $700 million investment in Radiology Partners.
- Starr Investment Holdings, LLC on the acquisition of ACA Compliance from New Mountain Capital.
Prior to joining Kirkland, Charles' representative matters included:
- HNA’s Swissport in its acquisition of the Aerocare Group.
- Dell Inc. on the sale of its IT consulting division to NTT Data Corp for US$3.05 billion.
- The shareholders of Menulog Group Limited on the sale of their shares in that company to JUST EAT plc for A$855 million.
- LabCorp on the acquisition of Chiltern for US$1.2 billion.
- Partners Group on various acquisitions within Australia.
- Cinven on the acquisition of an Australian pharmaceuticals manufacturer and distributor.
- The Shell Petroleum Company Limited on the sale of its Australian downstream assets to Vitol for A2.9 billion.
- Apache Corporation on the sale of its interests in the Wheatstone LNG project to Woodside Energy Limited for US$2.75 billion.
- Intuit Inc. on the acquisition of MTS Global (Europe) Limited.
- Gateway Lifestyle on its A$500 million initial public offering on the Australian Securities Exchange.
